Processing your payment...
Please do not close your browser.

OTC Artificial Tears Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: Allergan, Santen Pharmaceutical Co., Ltd., Bausch & Lomb, Alcon

30 May, 2022 | 98 Pages
Shares
facebook sharing button
linkedin sharing button
twitter sharing button
sharethis sharing button

The global OTC artificial tears market reached a value of US$ 4.75 Billion in 2021. Looking ahead, the market is expected to reach $6.90 billion by 2027, growing at a CAGR of 5.80% between 2022 and 2027.



OTC Artificial Tears Market Overview



Artificial tears are lubricant eye drops intended to relieve dryness and irritation caused by a lack of tear production. These artificial tears are created to mimic natural tears and are used to treat a variety of eye conditions such as allergies, infections, and UV and blue light protection. It was also used to keep the contact lenses wet.



Because of the increased prevalence of dry eye condition and eye surgeries, the development of effective over-the-counter artificial tears has become critical. Depending on the indication, OTC artificial tears are available in a variety of dosage forms, including solution, ointment, emulsion, gel, spray solution, and suspension. Over the years, market participants have focused on developing unique methodologies for the creation of OTC artificial tears, such as small molecule, biologic, and recombinant technologies. The OTC artificial tears market is expected to grow due to increased investment in R&D for the creation of new artificial tears for the treatment of dry eye syndrome, allergies, and UV and blue light protection, as well as an increase in the geriatric population. Furthermore, there has been a rise in public awareness of dry eye condition.



The report aspects discussed the profile of the top manufacturers of the global OTC Artificial Tears market. These aspects include financial status of major companies, trending advancements and entire market scenario. Growth of the report have examined OTC Artificial Tears Market production, demand and growth potential, geographic analysis, as well as current market developments in various regions and countries.





Industry News and Updates:



02.23.2021: Allergan Launches Refresh Digital Lubricant Eye Drops--

Allergan announced the over-the-counter (OTC) launch of Refresh Digital, a new lubricant eye drop formulated to specifically relieve dryness and irritation that may occur from prolonged screen time. Refresh Digital features proprietary HydroCell technology that supports all three layers of the tear film to keep eyes hydrated.



17 November 2020: Santen launches long-lasting ‘artificial tear’ treatment and online educational resource to support sufferers in the UK--

Dry eye – a common eye condition which affects 1 in 4 people in the UK1 – is a particularly sore point for women of menopausal or post-menopausal age, regular screen users and contact lens wearers, according to results of a new 2,000+ person survey commissioned by leading eye care specialist, Santen. Despite these groups being among the most likely to have dry eye, more than half (53%) of those surveyed didn’t realise they were at risk.2* Nearly a third of those with dry eye disease (32%) agreed that they didn’t know where to find information on the condition, and almost half (42%) of respondents who were using treatment for their dry eye disease said it took between one and three years to find an effective treatment.



What are the major Applications, Types and Regions for OTC Artificial Tears Market?



Market is segmented based on the type, applications, companies and regions.



By Type, it is segmented into




  • Preservative Based

  • Non-preservative Based



By Application, it is segmented into




  • Hospital Pharmacies

  • Drug Stores

  • Online



OTC Artificial Tears Market Regional Analysis



North America contributed more than one-third of the total market share in 2019 and is predicted to continue its leading share in terms of revenue by 2028, owing to an increase in the prevalence of dry eye syndrome, growth in advanced healthcare infrastructure, increased awareness, and the presence of significant market competitors in the region. However, the Asia-Pacific market is expected to grow at the fastest rate of 6.0% during the forecast period, owing to a growth in the elderly population, an increase in the number of cataract and glaucoma surgeries, and an increase in environmental pollution.




  • North America


    • US

    • Canada



  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe



  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Rest of the World

    • Middle East & Africa

    • Latin America





The OTC Artificial Tears Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global OTC Artificial Tears Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.



What is our OTC Artificial Tears Market report scope?























































Report Attributes



Report Details



Forecast Period 2022 to 2027 CAGR



CAGR of 5.80% over the forecast period (2022-2027)



By Type




  • Preservative Based

  • Non-preservative Based



By Application




  • Hospital Pharmacies

  • Drug Stores

  • Online



By Companies



Allergan (AbbVie Inc.) (Dublin, Ireland), Santen Pharmaceutical Co., Ltd. (Osaka, Japan), Bausch & Lomb (Laval, Canada), Alcon (Geneva, Switzerland), Novartis AG (Basel, Switzerland), Akorn Inc. (Lake Forest, U.S.), Eyevance Pharmaceuticals LLC (Forth Worth, U.S.), Sun Pharmaceutical Industries Ltd. (Mumbai, India), Johnson & Johnson (New Brunswick, U.S.), Bayer AG (Leverkusen, Germany), Otsuka Pharmaceutical Co., Ltd. (Tokyo, Japan)



Regions Covered




  • North America

  • Europe

  • Asia-Pacific

  • Rest of the World



Countries Covered




  • US

  • Canada

  • Germany

  • France

  • UK

  • Italy

  • Spain

  • Rest of Europe

  • China

  • Japan

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific

  • Middle East & Africa

  • Latin America



Base Year



2022



Historical Year



2017 to 2021



Forecast Year



2022 to 2027



Number of Pages



98



Customization Available



Yes, the report can be customized as per your needs




 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



Frequently Asked Questions



What is the growth rate of OTC Artificial Tears Market?



The OTC Artificial Tears Market is growing at a CAGR of 5.80% over the next 5 years.



Who are the key players in OTC Artificial Tears Market?



Allergan (AbbVie Inc.) (Dublin, Ireland), Santen Pharmaceutical Co., Ltd. (Osaka, Japan), Bausch & Lomb (Laval, Canada), Alcon (Geneva, Switzerland), Novartis AG (Basel, Switzerland), Akorn Inc. (Lake Forest, U.S.), Eyevance Pharmaceuticals LLC (Forth Worth, U.S.), Sun Pharmaceutical Industries Ltd. (Mumbai, India), Johnson & Johnson (New Brunswick, U.S.), Bayer AG (Leverkusen, Germany), Otsuka Pharmaceutical Co., Ltd. (Tokyo, Japan)



What are the significant types of OTC Artificial Tears Market?



Preservative Based, Non-preservative Based



What are the major end-use applications of OTC Artificial Tears Market?



Hospital Pharmacies, Drug Stores, Online



All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.


  1. INTRODUCTION

    1. MARKET DEFINATION

    2. MARKET DYNAMICS

    3. MARKET SEGMENTATION

    4. REPORT TIMLINES

    5. KEY STAKEHOLDERS



  2. RESEARCH METHODOLOGY

    1. DATA MINING

      1. SECONDARY RESEARCH

      2. PRIMARY RESEARCH

      3. SUBJECT MATTER EXPERT ADVICE



    2. QUALITY CHECK

    3. FINAL REVIEW

      1. DATA TRIANGULATION

      2. BOTTOM-UP APPROACH

      3. TOP-DOWN APPROACH



    4. RESEARCH FLOW



  3. EXECUTIVE SUMMARY

    1. INTRODUCTION

    2. GLOBAL OTC ARTIFICIAL TEARS MARKET BY TYPE

    3. GLOBAL OTC ARTIFICIAL TEARS MARKET BY APPLICTAION



  4. MARKET DYNAMICS

    1. DRIVERS

      1. INCREASING DEMAND FOR OTC ARTIFICIAL TEARS



    2. RESTRAINTS

      1. STRINGENT ENVIRONMENTAL REGUALTIONS

      2. HIGH COST ON MATERIALS



    3. OPPORTUNITIES

      1. OTC ARTIFICIAL TEARS GROWTH

      2. APPLICATION OF OTC ARTIFICIAL TEARS



    4. IMPACT OF COVID 19



  5. GLOBAL OTC ARTIFICIAL TEARS MARKET, BY TYPE

    1. INTRODUCTION

    2. PRESERVATIVE BASED

    3. NON-PRESERVATIVE BASED



  6. GLOBAL OTC ARTIFICIAL TEARS MARKET, BY APPLICATION

    1. INTRODUCTION

    2. HOSPITAL PHARMACIES

    3. DRUG STORES

    4. ONLINE



  7. GLOBAL OTC ARTIFICIAL TEARS MARKET, BY REGION

    1. NORTH AMERICA

      1. US

      2. CANADA

      3. MEXICO



    2. EUROPE

      1. GERMANY

      2. FRANCE

      3. UK

      4. ITALY

      5. RUSSIA

      6. REST OF EUROPE



    3. APAC

      1. CHINA

      2. SOUTH KOREA

      3. JAPAN

      4. INDIA

      5. AUSTRALIA

      6. ASEAN

      7. REST OF APAC



    4. MIDDLE EAST & AFRICA

      1. SAUDI ARABIA

      2. UAE

      3. SOUTH AFRICA

      4. TURKEY

      5. REST OF MEA



    5. SOUTH AMERICA

      1. BRAZIL

      2. REST OF MEA

      3. ARGENTINA

      4. REST OF SOUTH AMERICA





  8. COMPETITIVE LANDSCAPE

    1. MERGERS, ACQUISITIONS, JOINT VENTURES, COLLABORATIONS,

    2. AND AGREEMENTS

      1. KEY DEVELOPMENT



    3. MARKET SHARE (%) **/RANKING ANALYSIS

    4. STRATEGIES ADOPTED BY LEADING PLAYERS



  9. COMPANY PROFILES

    1. BUSINESS OVERVIEW

    2. COMPANY SNAPSHOT

    3. PRODUCT BENCHMARKING

    4. STRATEGIC INITIATIVES

      1. ALLERGAN (ABBVIE INC.) (DUBLIN, IRELAND)

      2. SANTEN PHARMACEUTICAL CO., LTD. (OSAKA, JAPAN)

      3. BAUSCH & LOMB (LAVAL, CANADA)

      4. ALCON (GENEVA, SWITZERLAND)

      5. NOVARTIS AG (BASEL, SWITZERLAND)

      6. AKORN INC. (LAKE FOREST, U.S.)

      7. EYEVANCE PHARMACEUTICALS LLC (FORTH WORTH, U.S.)

      8. SUN PHARMACEUTICAL INDUSTRIES LTD. (MUMBAI, INDIA)

      9. JOHNSON & JOHNSON (NEW BRUNSWICK, U.S.)

      10. BAYER AG (LEVERKUSEN, GERMANY)

      11. OTSUKA PHARMACEUTICAL CO., LTD. (TOKYO, JAPAN)





SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

  • Single User License
    $2500
  • Site License
    $3000
  • Global License
    $5000

How can we help you?

Reach us with your research requirements and we shall provide the optimum solution to suit your needs.

Curioust about Multiple Reports?

Discounts available for multiple report purchases.

Contact Us

Our Clients

  • 3M
  • Merck
  • IBM
  • Dow
  • Henkel
  • AirBus
  • Cummins
  • Intel
  • Sony